BIX01294 treatment had no significant effect on G9a expression in neuroblastoma cells, but it led to a marked down-regulation of H3K9me2, which was reported to be a major product in G9a-mediated H3K9 methylation [6] (Fig. 4C). This evidence concerns the gene EHMT2 and neuroblastoma.